Updated from 9:27 a.m. ESTAnalysts from a string of brokerages sang the praises of WellPoint ( WLP) Tuesday after it delivered strong fourth-quarter earnings growth and suggested the outlook for the industry remains bright. "Earnings were rock solid," noted Todd Richter, an analyst at Banc of America, who maintained his buy rating on the stock. "It was another typical WellPoint quarter." Legg Mason, UBS Warburg, SG Cowen and Merrill Lynch all reiterated their strong buy ratings Tuesday and several analysts also raised their 2002 earnings estimates and price targets. WellPoint rose 2% to $130.63 after hitting an all-time high earlier. The Morgan Stanley Healthcare index was up 1% to 494.30, also just shy of its all-time high that it hit last week.